ARTICLE | Clinical News
Nivestim filgrastim regulatory update
October 4, 2010 7:00 AM UTC
The Australian Therapeutic Goods Administration (TGA) approved biosimilar Nivestim filgrastim from Hospira to prevent febrile neutropenia and to reduce the duration of chemotherapy-induced neutropenia...